Dr. Graybill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2006 - 2010
- University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 2002 - 2006
- East Tennessee State University James H. Quillen College of MedicineClass of 2002
Certifications & Licensure
- SC State Medical License 2010 - 2025
- TX State Medical License 2008 - 2011
- AL State Medical License 2004 - 2006
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
- IMGN853 With Carboplatin in Second-line Treatment of FRα Expressing, Platinum-sensitive Epithelial Ovarian Cancer Start of enrollment: 2022 Sep 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.Whitney S Graybill, Ignace Vergote, Bhavana Pothuri, Maarit Anttila, David M O'Malley
Journal of Comparative Effectiveness Research. 2025-01-01 - 1 citationsPatterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An a...Mitchell R Kamrava, Antonio Gonzalez-Martin, Bhavana Pothuri, Ignace Vergote, Whitney Graybill
Gynecologic Oncology. 2024-10-01 - Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer.Bradley J Monk, Ignacio Romero, Whitney Graybill, Cristina Churruca, David M O'Malley
Clinical Therapeutics. 2024-08-01
Press Mentions
- Young Uterine Cancer Patient Reflects on JourneyJuly 29th, 2024
- Having Meaningful Conversations After a Cancer DiagnosisOctober 31st, 2017
- Having Meaningful Conversations After a Cancer DiagnosisOctober 25th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: